Ultra-high dose Methylcobalamin (E0302) prolongs survival of ALS: Report of 7 years ‘randomised double-blind, Phase III clinical trial.” Abstract - Kaji, R; Kuzuhara, S; Iwasaki, Y (American Academy of Neurology Meeting, 2015)
P7.060